Vectura Limited

Royaume‑Uni

Retour au propriétaire

1-69 de 69 pour Vectura Limited Trier par
Recheche Texte
Affiner par
Type PI
        Brevet 45
        Marque 24
Juridiction
        International 27
        États-Unis 21
        Canada 12
        Europe 9
Date
2023 3
2022 1
2021 2
2020 9
Avant 2020 54
Classe IPC
A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier 18
A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres 17
A61K 31/40 - Composés hétérocycliques ayant l'azote comme hétéro-atome d'un cycle, p. ex. guanéthidine ou rifamycines ayant des cycles à cinq chaînons avec un azote comme seul hétéro-atome d'un cycle, p. ex. sulpiride, succinimide, tolmétine, buflomédil 10
A61K 9/16 - AgglomérésGranulésMicrobilles 7
A61K 9/72 - Préparations médicinales caractérisées par un aspect particulier à fumer ou inhaler 7
Voir plus
Classe NICE
05 - Produits pharmaceutiques, vétérinaires et hygièniques 22
42 - Services scientifiques, technologiques et industriels, recherche et conception 22
10 - Appareils et instruments médicaux 21
01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture 14
16 - Papier, carton et produits en ces matières 3
Voir plus
Statut
En Instance 2
Enregistré / En vigueur 67

1.

POWDERHALE

      
Numéro de série 98286234
Statut Enregistrée
Date de dépôt 2023-11-27
Date d'enregistrement 2024-10-22
Propriétaire Vectura Limited (Royaume‑Uni)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 10 - Appareils et instruments médicaux

Produits et services

Pharmaceutical and veterinary preparations for the treatment of diseases or conditions of the respiratory system; pharmaceutical and veterinary preparations for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions; pharmaceutical and veterinary preparations for the alleviation or prevention of pain or inflammation; inhalers filled with powders for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions; pharmaceutical preparations, namely, powders for asthma inhalers; pharmaceutical preparations, namely, powders for transdermal injection for the alleviation or prevention of pain, for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions; pharmaceutical and veterinary preparations for oral ingestion for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions; pharmaceutical and veterinary preparations for topical administration for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions; pharmaceutical and veterinary preparations for erectile dysfunction; pharmaceutical and veterinary preparations for chronic obstructive pulmonary disease; pharmaceutical and veterinary preparations for premature ejaculation; pharmaceutical and veterinary preparations for cystic fibrosis; pharmaceutical and veterinary preparations for female sexual dysfunction; medicaments for migraine; pharmaceutical and veterinary preparations for asthma Inhalers for medical purposes, sold empty; metered dose inhalers for medical purposes, sold empty; active dry powder inhalers for medical purposes, sold empty; passive dry powder inhalers for medical purposes, sold empty; nebulisers for respiration therapy; respirators for artificial respiration and parts and fittings for all the aforesaid goods

2.

VECTURA

      
Numéro de série 98217245
Statut En instance
Date de dépôt 2023-10-10
Propriétaire Vectura Limited (Royaume‑Uni)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
  • 10 - Appareils et instruments médicaux
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Pharmaceutical and veterinary preparations for the treatment of diseases or conditions of the respiratory system; pharmaceutical and veterinary preparations for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynaecological conditions; pharmaceutical and veterinary preparations for the alleviation or prevention of pain or inflammation; inhalers filled with powders for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynaecological conditions; pharmaceutical preparations, namely, powders for asthma inhalers; pharmaceutical preparations, namely, powders for transdermal injection for the alleviation or prevention of pain, for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions; pharmaceutical and veterinary preparations for oral ingestion for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions; pharmaceutical and veterinary preparations for topical administration for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions; medicaments for inhalation therapy; pharmaceutical preparations, namely, pulmonary delivery compositions for use in facilitating the inhalation of pharmaceuticals, namely, drug delivery agents consisting of compounds that facilitate delivery by inhalation of a wide range of pharmaceuticals; medicaments for the treatment of erectile dysfunction; medicaments for the treatment of chronic obstructive pulmonary disease; medicaments for the treatment of premature ejaculation; medicaments for the treatment of cystic fibrosis; medicaments for the treatment of female sexual dysfunction; medicaments for the treatment of migraines; medicaments for the treatment of asthma; all of the above goods not for use in the dental field Custom manufacture of pharmaceuticals; Consulting services in the field of pharmaceutical formulation, development of medical applications for drugs and pharmaceutical formulations, drug design, drug formulation, pharmaceutical formulation, and development of pharmaceutical formulations Surgical, medical, and veterinary apparatus, instruments and parts and fittings therefor, namely, drug delivery devices and parts and fittings therefor, namely, drug delivery systems being nebulizers for medical purposes; inhalers sold empty for medical or therapeutic purposes and parts and fittings therefor; active dry powder inhalers sold empty for medical or therapeutic purposes and parts and fittings therefor; passive dry powder inhalers sold empty for medical or therapeutic purposes and parts and fittings therefor; nebulisers for inhalation therapy, namely, respiration therapy, and parts and fittings therefor; inhaler devices sold empty for medical or therapeutic purposes and parts and fittings therefor; all of the above goods not for use in the dental field Scientific research and technological services, namely, research, design, analysis, and testing, in the field of pharmaceuticals and drug delivery systems, and drug delivery systems and devices; Scientific research and technological services, namely, research in the field of medicine; industrial analysis and research services in the fields of drug delivery systems and devices; research services in the fields of medicine; pharmaceutical research services; pharmaceutical products development services; device and product safety testing services;

3.

COMPOSITIONS FOR THE TREATMENT OF A RESPIRATORY CONDITION

      
Numéro d'application 17928271
Statut En instance
Date de dépôt 2021-03-26
Date de la première publication 2023-06-29
Propriétaire VECTURA LIMITED (Royaume‑Uni)
Inventeur(s) Manford, Fergus

Abrégé

The present disclosure relates to the administration of a composition comprising an interferon, azithromycin and chloroquine for the treatment of respiratory conditions.

Classes IPC  ?

  • A61K 38/21 - Interférons
  • A61K 31/4706 - 4-Aminoquinoléines8-Aminoquinoléines, p. ex. chloroquine, primaquine
  • A61K 31/7052 - Composés ayant des radicaux saccharide et des hétérocycles ayant l'azote comme hétéro-atome d'un cycle, p. ex. nucléosides, nucléotides
  • A61P 31/14 - Antiviraux pour le traitement des virus ARN

4.

Jet milling method

      
Numéro d'application 17554042
Numéro de brevet 11759791
Statut Délivré - en vigueur
Date de dépôt 2021-12-17
Date de la première publication 2022-04-07
Date d'octroi 2023-09-19
Propriétaire Vectura Limited (USA)
Inventeur(s)
  • Manford, Fergus
  • Green, Matthew

Abrégé

Systems and methods are disclosed for simultaneously jet milling and conditioning particulate material comprising a grinding chamber and an aerosol generator arranged to supply liquid aerosol into the grinding chamber. A composition made by this method is also disclosed.

Classes IPC  ?

  • B02C 19/06 - Appareils utilisant un courant de fluides
  • A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres
  • A61K 31/40 - Composés hétérocycliques ayant l'azote comme hétéro-atome d'un cycle, p. ex. guanéthidine ou rifamycines ayant des cycles à cinq chaînons avec un azote comme seul hétéro-atome d'un cycle, p. ex. sulpiride, succinimide, tolmétine, buflomédil
  • B02C 23/18 - Addition de fluide, dans un but autre que celui de broyer ou de désagréger par l'énergie du fluide

5.

COMPOSITIONS FOR THE TREATMENT OF A RESPIRATORY CONDITION

      
Numéro d'application EP2021058041
Numéro de publication 2021/191456
Statut Délivré - en vigueur
Date de dépôt 2021-03-26
Date de publication 2021-09-30
Propriétaire VECTURA LIMITED (Royaume‑Uni)
Inventeur(s) Manford, Fergus

Abrégé

The present disclosure relates to the administration of a composition comprising an interferon, azithromycin and chloroquine for the treatment of respiratory conditions.

Classes IPC  ?

  • A61K 31/4706 - 4-Aminoquinoléines8-Aminoquinoléines, p. ex. chloroquine, primaquine
  • A61K 31/7052 - Composés ayant des radicaux saccharide et des hétérocycles ayant l'azote comme hétéro-atome d'un cycle, p. ex. nucléosides, nucléotides
  • A61K 38/21 - Interférons
  • A61P 11/00 - Médicaments pour le traitement des troubles du système respiratoire
  • A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
  • A61K 47/26 - Hydrates de carbone, p. ex. polyols ou sucres alcoolisés, sucres aminés, acides nucléiques, mono-, di- ou oligosaccharidesLeurs dérivés, p. ex. polysorbates, esters d’acide gras de sorbitan ou glycyrrhizine

6.

Polymer

      
Numéro d'application 16321615
Numéro de brevet 11583587
Statut Délivré - en vigueur
Date de dépôt 2017-07-28
Date de la première publication 2021-05-13
Date d'octroi 2023-02-21
Propriétaire Vectura Limited (USA)
Inventeur(s)
  • Stolnik-Trenkic, Snjezana
  • Mantovani, Giuseppe
  • Nieto Orellana, Alejandro

Abrégé

A PEGylated polymer is disclosed according to Formula 1 wherein n is any integer from 4 to 200 monomers, and R is a polymer chain comprising a 4 to 200-monomer moiety.

Classes IPC  ?

  • A61K 47/60 - Préparations médicinales caractérisées par les ingrédients non actifs utilisés, p. ex. les supports ou les additifs inertesAgents de ciblage ou de modification chimiquement liés à l’ingrédient actif l’ingrédient non actif étant chimiquement lié à l’ingrédient actif, p. ex. conjugués polymère-médicament l’ingrédient non actif étant un agent de modification l’agent de modification étant un composé organique macromoléculaire, p. ex. une molécule oligomérique, polymérique ou dendrimérique obtenu par des réactions autres que celles faisant intervenir uniquement des liaisons non saturées carbone-carbone, p. ex. polyurées ou polyuréthanes le composé organique macromoléculaire étant un oligomère, un polymère ou un dendrimère de polyoxyalkylène, p. ex. PEG, PPG, PEO ou polyglycérol
  • A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
  • A61K 39/395 - AnticorpsImmunoglobulinesImmunsérum, p. ex. sérum antilymphocitaire
  • C08G 69/42 - Polyamides contenant des atomes autres que le carbone, l'hydrogène, l'oxygène et l'azote

7.

V

      
Numéro d'application 1552158
Statut Enregistrée
Date de dépôt 2020-08-03
Date d'enregistrement 2020-08-03
Propriétaire VECTURA LIMITED (Royaume‑Uni)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 10 - Appareils et instruments médicaux
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Chemical substances and products for use in the manufacture of medical preparations. Medical preparations; pharmaceutical preparations for medical purposes; biological preparations for medical purposes; pharmaceutical preparations formulated for pulmonary delivery via inhalation; pharmaceutical preparations for the prevention or treatment of diseases or conditions of the respiratory and cardiovascular systems. Medical apparatus and instruments; drug delivery devices; inhalers; metered dose inhalers; active dry powder inhalers; passive dry powder inhalers; nebulisers for respiration therapy; respirators for artificial respiration; parts and fittings for all the aforesaid goods. Scientific research, development, design, analysis, testing and investigation relating to medical preparations and drug delivery devices; medical research; research relating to drug delivery devices; research relating to drug formulation; pharmaceutical development; preparation and formulation of pharmaceuticals; device and product testing.

8.

VECTURA

      
Numéro d'application 1551854
Statut Enregistrée
Date de dépôt 2020-08-03
Date d'enregistrement 2020-08-03
Propriétaire VECTURA LIMITED (Royaume‑Uni)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 10 - Appareils et instruments médicaux
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Chemical substances and products for use in the manufacture of medical preparations. Medical preparations; pharmaceutical preparations for medical purposes; biological preparations for medical purposes; pharmaceutical preparations formulated for pulmonary delivery via inhalation; pharmaceutical preparations for the prevention or treatment of diseases or conditions of the respiratory and cardiovascular systems. Medical apparatus and instruments; drug delivery devices; inhalers; metered dose inhalers; active dry powder inhalers; passive dry powder inhalers; nebulisers for respiration therapy; respirators for artificial respiration; parts and fittings for all the aforesaid goods. Scientific research, development, design, analysis, testing and investigation relating to medical preparations and drug delivery devices; medical research; research relating to drug delivery devices; research relating to drug formulation; pharmaceutical development; preparation and formulation of pharmaceuticals; device and product testing.

9.

V

      
Numéro d'application 205359100
Statut Enregistrée
Date de dépôt 2020-08-03
Date d'enregistrement 2023-07-05
Propriétaire VECTURA LIMITED (Royaume‑Uni)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 10 - Appareils et instruments médicaux
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

(1) Chemical substances and products for use in the manufacture of medical preparations for treating respiratory diseases. (2) Medical preparations for treating respiratory diseases; pharmaceutical preparations for treating respiratory diseases; biological preparations for treating respiratory diseases; pharmaceutical preparations formulated for pulmonary delivery via inhalation for treating respiratory diseases; pharmaceutical preparations for the prevention and treatment of diseases and conditions of the respiratory and cardiovascular systems (3) Medical apparatus and instruments, namely, inhalers, metered dose inhalers, active dry powder inhalers and passive dry powder inhalers, and parts and fittings for all the aforesaid goods; nebulisers for respiration therapy, and parts and fittings for all the aforesaid goods; respirators for artificial respiration; and parts and fittings for all the aforesaid goods (1) Scientific research, development, design, analysis, testing and investigation relating to medical preparations and drug delivery devices; medical research; research relating to drug delivery devices namely for treating respiratory diseases; research relating to drug formulation for respiratory diseases; pharmaceutical development; preparation and formulation of pharmaceuticals for treating respiratory diseases; medical devices and product testing in the field of pharmaceutical preparations and drug delivery devices

10.

V VECTURA

      
Numéro d'application 205359400
Statut Enregistrée
Date de dépôt 2020-08-03
Date d'enregistrement 2023-07-05
Propriétaire VECTURA LIMITED (Royaume‑Uni)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 10 - Appareils et instruments médicaux
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

(1) Chemical substances and products for use in the manufacture of medical preparations for treating respiratory diseases (2) Medical preparations for treating respiratory diseases; pharmaceutical preparations for treating respiratory diseases; biological preparations for treating respiratory diseases; pharmaceutical preparations formulated for pulmonary delivery via inhalation for treating respiratory diseases; pharmaceutical preparations for the prevention or treatment of diseases or conditions of the respiratory and cardiovascular systems (3) Medical apparatus and instruments, namely, inhalers, metered dose inhalers, active dry powder inhalers and passive dry powder inhalers, and parts and fittings for all the aforesaid goods; nebulisers for respiration therapy, and parts and fittings for all the aforesaid goods; respirators for artificial respiration and parts and fittings for all the aforesaid goods (1) Scientific research, development, design, analysis, testing and investigation relating to medical preparations and drug delivery devices; medical research; research relating to drug delivery devices namely for treating respiratory diseases; research relating to drug formulation for respiratory diseases; pharmaceutical development; preparation and formulation of pharmaceuticals for treating respiratory diseases; medical devices and product testing in the field of pharmaceutical preparations and drug delivery devices

11.

V

      
Numéro de série 79294440
Statut Enregistrée
Date de dépôt 2020-08-03
Date d'enregistrement 2021-10-05
Propriétaire VECTURA LIMITED (Royaume‑Uni)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 10 - Appareils et instruments médicaux
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Chemical additives for use in the manufacture of medical preparations Medical preparations for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynaecological conditions; pharmaceutical preparations for medical purposes for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynaecological conditions; biological preparations for medical purposes for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynaecological conditions; pharmaceutical preparations for treating pulmonary diseases via inhalation; pharmaceutical preparations for the prevention and treatment of diseases and conditions of the respiratory and cardiovascular systems Medical apparatus and instruments, namely inhalers; drug delivery devices, namely inhalers; inhalers for medical use; metered dose inhalers for medical use; active dry powder inhalers for medical use; passive dry powder inhalers for medical use; nebulisers for respiration therapy; respirators for artificial respiration; component parts and fittings for all the aforesaid goods Scientific research relating to medical preparations and drug delivery devices; development and design medical preparations and drug delivery devices; analysis, and investigation in the form of testing of medical preparations and drug delivery devices; medical research; research relating to drug delivery devices; research relating to drug formulation; pharmaceutical development

12.

VECTURA

      
Numéro de série 79294323
Statut Enregistrée
Date de dépôt 2020-08-03
Date d'enregistrement 2021-10-05
Propriétaire VECTURA LIMITED (Royaume‑Uni)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 10 - Appareils et instruments médicaux
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Chemical additives for use in the manufacture of medical preparations Medical preparations for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynaecological conditions; pharmaceutical preparations for medical purposes for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynaecological conditions; biological preparations for medical purposes for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynaecological conditions; pharmaceutical preparations for treating pulmonary diseases via inhalation; pharmaceutical preparations for the prevention and treatment of diseases and conditions of the respiratory and cardiovascular systems Medical apparatus and instruments, namely inhalers; drug delivery devices, namely inhalers; inhalers for medical use; metered dose inhalers for medical use; active dry powder inhalers for medical use; passive dry powder inhalers for medical use; nebulisers for respiration therapy; respirators for artificial respiration; component parts and fittings for all the aforesaid goods Scientific research relating to medical preparations and drug delivery devices; development and design medical preparations and drug delivery devices; analysis, and investigation in the form of testing of medical preparations and drug delivery devices; medical research; research relating to drug delivery devices; research relating to drug formulation; pharmaceutical development

13.

Method for making a micronized dry powder formulation of glycopyrrolate and magnesium stearate

      
Numéro d'application 16493866
Numéro de brevet 11219602
Statut Délivré - en vigueur
Date de dépôt 2018-03-14
Date de la première publication 2020-03-12
Date d'octroi 2022-01-11
Propriétaire VECTURA LIMITED (Royaume‑Uni)
Inventeur(s)
  • Manford, Fergus Paul
  • Green, Matthew

Abrégé

Methods are disclosed for simultaneously jet milling and conditioning particulate glycopyrrolate and magnesium stearate using a milling gas having humidity between 5% and 30% Relative Humidity in the grinding chamber of a jet mill, the jet mill is configured with a humidifier arranged to supply humidity into the grinding chamber. A composition and formulation comprising physically stable micronized composite glycopyrrolate particles made by this method is also disclosed.

Classes IPC  ?

  • C07D 207/12 - Atomes d'oxygène ou de soufre
  • A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres
  • A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
  • A61K 31/40 - Composés hétérocycliques ayant l'azote comme hétéro-atome d'un cycle, p. ex. guanéthidine ou rifamycines ayant des cycles à cinq chaînons avec un azote comme seul hétéro-atome d'un cycle, p. ex. sulpiride, succinimide, tolmétine, buflomédil
  • A61K 31/4704 - 2-Quinolones, p. ex. carbostyrile
  • A61K 31/573 - Composés contenant des systèmes cycliques du cyclopenta[a]hydrophénanthrèneLeurs dérivés, p. ex. stéroïdes substitués en position 17 bêta par une chaîne à deux atomes de carbone, p. ex. prégnane ou progestérone substitués en position 21, p. ex. cortisone, dexaméthasone, prednisone ou aldostérone

14.

Miscellaneous Design

      
Numéro d'application 018198068
Statut Enregistrée
Date de dépôt 2020-02-18
Date d'enregistrement 2020-07-04
Propriétaire VECTURA LIMITED (Royaume‑Uni)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 10 - Appareils et instruments médicaux
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Chemical substances and products for use in the manufacture of medical preparations. Medical preparations; pharmaceutical preparations for medical purposes; biological preparations for medical purposes; pharmaceutical preparations formulated for pulmonary delivery via inhalation; pharmaceutical preparations for the prevention or treatment of diseases or conditions of the respiratory and cardiovascular systems. Medical apparatus and instruments; drug delivery devices; inhalers; metered dose inhalers; active dry powder inhalers; passive dry powder inhalers; nebulisers for respiration therapy; respirators for artificial respiration; parts and fittings for all the aforesaid goods. Scientific research, development, design, analysis, testing and investigation relating to medical preparations and drug delivery devices; medical research; research relating to drug delivery devices; research relating to drug formulation; pharmaceutical development; preparation and formulation of pharmaceuticals; device and product testing.

15.

VECTURA

      
Numéro d'application 018198071
Statut Enregistrée
Date de dépôt 2020-02-18
Date d'enregistrement 2020-07-04
Propriétaire VECTURA LIMITED (Royaume‑Uni)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 10 - Appareils et instruments médicaux
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Chemical substances and products for use in the manufacture of medical preparations. Medical preparations; pharmaceutical preparations for medical purposes; biological preparations for medical purposes; pharmaceutical preparations formulated for pulmonary delivery via inhalation; pharmaceutical preparations for the prevention or treatment of diseases or conditions of the respiratory and cardiovascular systems. Medical apparatus and instruments; drug delivery devices; inhalers; metered dose inhalers; active dry powder inhalers; passive dry powder inhalers; nebulisers for respiration therapy; respirators for artificial respiration; parts and fittings for all the aforesaid goods. Scientific research, development, design, analysis, testing and investigation relating to medical preparations and drug delivery devices; medical research; research relating to drug delivery devices; research relating to drug formulation; pharmaceutical development; preparation and formulation of pharmaceuticals; device and product testing.

16.

Polymorphs

      
Numéro d'application 16113564
Numéro de brevet 10508123
Statut Délivré - en vigueur
Date de dépôt 2018-08-27
Date de la première publication 2019-01-31
Date d'octroi 2019-12-17
Propriétaire Vectura Limited (Royaume‑Uni)
Inventeur(s) Munro, Alexander

Abrégé

The invention relates to a polymorphic form of (S)-3-(3-(1-methyl-2-oxo-5-(pyrazolo[1,5-a]pyridine-3-yl)-1H-imidazo[4,5-b]pyridine-3(2H)-yl)piperidin-1-yl)-3-oxopropanenitrile and use as a therapeutic agent for the treatment of respiratory diseases.

Classes IPC  ?

  • C07D 519/00 - Composés hétérocycliques contenant plusieurs systèmes de plusieurs hétérocycles déterminants condensés entre eux ou condensés avec un système carbocyclique commun non prévus dans les groupes ou
  • A61K 47/26 - Hydrates de carbone, p. ex. polyols ou sucres alcoolisés, sucres aminés, acides nucléiques, mono-, di- ou oligosaccharidesLeurs dérivés, p. ex. polysorbates, esters d’acide gras de sorbitan ou glycyrrhizine

17.

Use of stearate in an inhalable formulation

      
Numéro d'application 16031102
Numéro de brevet 10729647
Statut Délivré - en vigueur
Date de dépôt 2018-07-10
Date de la première publication 2019-01-10
Date d'octroi 2020-08-04
Propriétaire Vectura Limited (Royaume‑Uni)
Inventeur(s) Green, Matthew

Abrégé

The present invention concerns a method for making an inhaled pharmaceutical composition with improved powder handling properties comprising a stearate, a method of preparing such a composition, and the use of such a stearate in a composition when dispensed into a receptacle for use in a dry powder inhaler receptacle.

Classes IPC  ?

  • A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
  • A61K 31/56 - Composés contenant des systèmes cycliques du cyclopenta[a]hydrophénanthrèneLeurs dérivés, p. ex. stéroïdes
  • A61K 47/12 - Acides carboxyliquesLeurs sels ou anhydrides

18.

METHOD AND FORMULATION

      
Numéro d'application EP2018056456
Numéro de publication 2018/167180
Statut Délivré - en vigueur
Date de dépôt 2018-03-14
Date de publication 2018-09-20
Propriétaire VECTURA LIMITED (Royaume‑Uni)
Inventeur(s)
  • Manford, Fergus Paul
  • Green, Matthew

Abrégé

Methods are disclosed for simultaneously jet milling and conditioning particulate glycopyrrolate and magnesium stearate using a milling gas having humidity between 5% and 30% Relative Humidity in the grinding chamber of a jet mill, the jet mill is configured with a humidifier arranged to supply humidity into the grinding chamber. A composition and formulation comprising physically stable micronized composite glycopyrrolate particles made by this method is also disclosed.

Classes IPC  ?

  • A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
  • A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres
  • A61K 31/40 - Composés hétérocycliques ayant l'azote comme hétéro-atome d'un cycle, p. ex. guanéthidine ou rifamycines ayant des cycles à cinq chaînons avec un azote comme seul hétéro-atome d'un cycle, p. ex. sulpiride, succinimide, tolmétine, buflomédil

19.

Jet milling method

      
Numéro d'application 15758642
Numéro de brevet 11229915
Statut Délivré - en vigueur
Date de dépôt 2016-09-09
Date de la première publication 2018-09-13
Date d'octroi 2022-01-25
Propriétaire VECTURA LIMITED (Royaume‑Uni)
Inventeur(s)
  • Manford, Fergus
  • Green, Matthew

Abrégé

Systems and methods are disclosed for simultaneously jet milling and conditioning particulate material comprising a grinding chamber and an aerosol generator arranged to supply liquid aerosol into the grinding chamber. A composition made by this method is also disclosed.

Classes IPC  ?

  • B02C 19/06 - Appareils utilisant un courant de fluides
  • A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres
  • A61K 31/40 - Composés hétérocycliques ayant l'azote comme hétéro-atome d'un cycle, p. ex. guanéthidine ou rifamycines ayant des cycles à cinq chaînons avec un azote comme seul hétéro-atome d'un cycle, p. ex. sulpiride, succinimide, tolmétine, buflomédil
  • B02C 23/18 - Addition de fluide, dans un but autre que celui de broyer ou de désagréger par l'énergie du fluide

20.

INHALABLE POWDER COMPOSITION COMPRISING IL-13 ANTIBODY

      
Numéro d'application EP2017077923
Numéro de publication 2018/078186
Statut Délivré - en vigueur
Date de dépôt 2017-10-31
Date de publication 2018-05-03
Propriétaire
  • VECTURA LIMITED (Royaume‑Uni)
  • UCB BIOPHARMA SPRL (Belgique)
Inventeur(s)
  • Morgan, Frazer Giles
  • Main, Mark Jonathan
  • Palframan, Roger
  • Kirke, David

Abrégé

An inhalable powder composition comprises a) an antagonistic antibody which binds human IL-13, b) leucine and c) trehalose. The antibody may comprise a heavy chain, wherein the variable domain of the heavy chain comprises the sequence given in SEQ ID NO:3 and a light chain, wherein the variable domain of the light chain comprises the sequence given in SEQ ID NO:1. Also described is the use of such compositions in the treatment of asthma, as well as inhalers containing such compositions.

Classes IPC  ?

  • C07K 16/24 - Immunoglobulines, p. ex. anticorps monoclonaux ou polyclonaux contre du matériel provenant d'animaux ou d'humains contre des cytokines, des lymphokines ou des interférons
  • A61K 39/395 - AnticorpsImmunoglobulinesImmunsérum, p. ex. sérum antilymphocitaire
  • A61K 9/16 - AgglomérésGranulésMicrobilles

21.

Crystalline form of a JAK3 kinase inhibitor

      
Numéro d'application 15555590
Numéro de brevet 10155757
Statut Délivré - en vigueur
Date de dépôt 2016-02-29
Date de la première publication 2018-02-15
Date d'octroi 2018-12-18
Propriétaire Vectura Limited (Royaume‑Uni)
Inventeur(s) Holland, Joanne

Abrégé

The invention relates to novel co-crystals of a drug substance and their use to treat respiratory diseases such as asthma and COPD.

Classes IPC  ?

22.

POLYMER

      
Numéro d'application EP2017069236
Numéro de publication 2018/020034
Statut Délivré - en vigueur
Date de dépôt 2017-07-28
Date de publication 2018-02-01
Propriétaire VECTURA LIMITED (Royaume‑Uni)
Inventeur(s)
  • Stolnik-Trenkic, Snjezana
  • Mantovani, Giuseppe
  • Nieto Orellana, Alejandro

Abrégé

A PEGylated polymer is disclosed according to Formula 1 wherein n is any integer from 4 to 200 monomers, and R is a polymer chain comprising a 4 to 200‐monomer moiety.

Classes IPC  ?

  • A61K 47/34 - Composés macromoléculaires obtenus par des réactions autres que celles faisant intervenir uniquement des liaisons non saturées carbone-carbone, p. ex. polyesters, acides polyaminés, polysiloxanes, polyphosphazines, copolymères de polyalkylène glycol ou de poloxamères
  • C08G 69/40 - Polyamides contenant de l'oxygène sous forme de groupes éther
  • A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
  • A61K 9/51 - Nanocapsules

23.

Polymorphs

      
Numéro d'application 15547657
Numéro de brevet 10087196
Statut Délivré - en vigueur
Date de dépôt 2016-01-27
Date de la première publication 2018-01-18
Date d'octroi 2018-10-02
Propriétaire VECTURA LIMITED (Royaume‑Uni)
Inventeur(s) Munro, Alexander

Abrégé

The invention relates to a polymorphic forms of (S)-3-(3-(1-methyl-2-oxo-5-(pyrazolo[1,5-a]pyridine-3-yl)-1H-imidazo[4,5-b]pyridine-3(2H)-yl)piperidin-1-yl)-3-oxopropanenitrile and their use as a therapeutic agent for the treatment of respiratory diseases.

Classes IPC  ?

  • C07D 519/00 - Composés hétérocycliques contenant plusieurs systèmes de plusieurs hétérocycles déterminants condensés entre eux ou condensés avec un système carbocyclique commun non prévus dans les groupes ou
  • A61K 47/26 - Hydrates de carbone, p. ex. polyols ou sucres alcoolisés, sucres aminés, acides nucléiques, mono-, di- ou oligosaccharidesLeurs dérivés, p. ex. polysorbates, esters d’acide gras de sorbitan ou glycyrrhizine

24.

Taurine compositions suitable for inhalation

      
Numéro d'application 15488616
Numéro de brevet 09907754
Statut Délivré - en vigueur
Date de dépôt 2017-04-17
Date de la première publication 2017-10-05
Date d'octroi 2018-03-06
Propriétaire VECTURA LIMITED (Royaume‑Uni)
Inventeur(s)
  • Farrow, David
  • Coggins, Katie

Abrégé

The invention discloses spray-dried compositions for inhalation and methods for preparing such powder compositions. The compositions of the invention are produced by spray-drying taurine under conditions that (i) retain the physical and chemical stability of the composition during spray drying and upon storage, (ii) protect the powder composition from aggregation and (iii) provide particles suitable for aerosolization.

Classes IPC  ?

  • A61K 9/16 - AgglomérésGranulésMicrobilles
  • A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
  • A61K 45/06 - Mélanges d'ingrédients actifs sans caractérisation chimique, p. ex. composés antiphlogistiques et pour le cœur
  • A61K 31/58 - Composés contenant des systèmes cycliques du cyclopenta[a]hydrophénanthrèneLeurs dérivés, p. ex. stéroïdes contenant des hétérocycles, p. ex. danazol, stanozolol, pancuronium ou digitogénine
  • A61K 31/185 - AcidesLeurs anhydrides, halogénures ou sels, p. ex. acides du soufre, acides imidiques, hydrazoniques ou hydroximiques
  • A61K 31/40 - Composés hétérocycliques ayant l'azote comme hétéro-atome d'un cycle, p. ex. guanéthidine ou rifamycines ayant des cycles à cinq chaînons avec un azote comme seul hétéro-atome d'un cycle, p. ex. sulpiride, succinimide, tolmétine, buflomédil
  • A61K 31/137 - Arylalkylamines, p. ex. amphétamine, épinéphrine, salbutamol, éphédrine
  • A61K 31/167 - Amides, p. ex. acides hydroxamiques ayant des cycles aromatiques, p. ex. colchicine, aténolol, progabide ayant l'atome d'azote d'un groupe carboxamide lié directement au cycle aromatique, p. ex. lidocaïne, paracétamol
  • A61K 31/439 - Composés hétérocycliques ayant l'azote comme hétéro-atome d'un cycle, p. ex. guanéthidine ou rifamycines ayant des cycles à six chaînons avec un azote comme seul hétéro-atome d'un cycle le cycle formant une partie d'un système cyclique ponté, p. ex. quinuclidine
  • A61K 31/4704 - 2-Quinolones, p. ex. carbostyrile
  • C07C 303/42 - SéparationPurificationStabilisationEmploi d'additifs
  • C07C 309/14 - Acides sulfoniques ayant des groupes sulfo liés à des atomes de carbone acycliques d'un squelette carboné acyclique saturé contenant des atomes d'azote, ne faisant pas partie de groupes nitro ou nitroso, liés au squelette carboné contenant des groupes amino liés au squelette carboné
  • A61K 31/138 - Aryloxyalkylamines, p. ex. propranolol, tamoxifène, phénoxybenzamine

25.

Formulation comprising glycopyrrolate, method and apparatus

      
Numéro d'application 15509769
Numéro de brevet 10532041
Statut Délivré - en vigueur
Date de dépôt 2014-09-09
Date de la première publication 2017-09-14
Date d'octroi 2020-01-14
Propriétaire Vectura Limited (Royaume‑Uni)
Inventeur(s) Manford, Fergus

Abrégé

A method is disclosed for making a pharmaceutical composition for pulmonary administration comprising co-jet milling glycopyrrolate and magnesium stearate, wherein the co-jet milled glycopyrrolate and magnesium stearate is then subjected to a conditioning step which includes exposure of the co-jet milled glycopyrrolate and magnesium stearate to humidity. A composition made by this method is also disclosed.

Classes IPC  ?

  • A61K 31/40 - Composés hétérocycliques ayant l'azote comme hétéro-atome d'un cycle, p. ex. guanéthidine ou rifamycines ayant des cycles à cinq chaînons avec un azote comme seul hétéro-atome d'un cycle, p. ex. sulpiride, succinimide, tolmétine, buflomédil
  • A61K 31/137 - Arylalkylamines, p. ex. amphétamine, épinéphrine, salbutamol, éphédrine
  • A61K 31/4704 - 2-Quinolones, p. ex. carbostyrile
  • A61K 31/573 - Composés contenant des systèmes cycliques du cyclopenta[a]hydrophénanthrèneLeurs dérivés, p. ex. stéroïdes substitués en position 17 bêta par une chaîne à deux atomes de carbone, p. ex. prégnane ou progestérone substitués en position 21, p. ex. cortisone, dexaméthasone, prednisone ou aldostérone
  • A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
  • A61K 9/50 - Microcapsules
  • A61K 9/51 - Nanocapsules
  • A61K 31/138 - Aryloxyalkylamines, p. ex. propranolol, tamoxifène, phénoxybenzamine

26.

VECTURA

      
Numéro d'application 184339800
Statut Enregistrée
Date de dépôt 2017-06-19
Date d'enregistrement 2020-04-22
Propriétaire Vectura Limited (Royaume‑Uni)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations for the treatment of diseases and conditions of the respiratory system none of the aforesaid wares are for use in the veterinary field or for use in association with autoimmune and inflammatory diseases and conditions; pharmaceutical preparations for the treatment of diseases and conditions of the respiratory system, diseases and conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases and conditions of the gastro-intestinal system, diseases and conditions of the central nervous system, namely encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, Huntington's disease and multiple sclerosis, central nervous system infections, brain diseases, nervous system infections movement disorders, ocular motility disorders, spinal cord diseases, diseases and conditions of the endocrine system, namely growth and thyroid disorders, diseases and conditions of the genito-urinary system, namely, cancer, infertility, sexually transmitted diseases, incontinence, and sexual dysfunction, infectious diseases, namely respiratory infections, bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections none of the aforesaid wares are for use in the veterinary field or for use in association with autoimmune and inflammatory diseases and conditions; pharmaceutical preparations for the alleviation and prevention of pain none of the aforesaid wares are for use in the veterinary field or for use in association with autoimmune and inflammatory diseases and conditions; inhalers filled with powders for the treatment of diseases and conditions of the respiratory system, diseases and conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases and conditions of the gastro-intestinal system, diseases and conditions of the central nervous system, namely encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, Huntington's disease and multiple sclerosis, central nervous system infections, brain diseases, nervous system infections movement disorders, ocular motility disorders, spinal cord diseases, diseases and conditions of the endocrine system, namely growth and thyroid disorders, diseases and conditions of the genito-urinary system, namely, cancer, infertility, sexually transmitted diseases, incontinence, and sexual dysfunction, infectious diseases, namely respiratory infections, bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections none of the aforesaid wares are for use in the veterinary field or for use in association with autoimmune and inflammatory diseases and conditions; pharmaceutical preparations, namely, powders for asthma inhalers none of the aforesaid wares are for use in the veterinary field or for use in association with autoimmune and inflammatory diseases and conditions; pharmaceutical preparations, namely, powders for transdermal injection for the alleviation and prevention of pain, for the treatment of diseases and conditions of the respiratory system, diseases and conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases and conditions of the gastro-intestinal system, diseases and conditions of the central nervous system, namely encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, Huntington's disease and multiple sclerosis, central nervous system infections, brain diseases, nervous system infections movement disorders, ocular motility disorders, spinal cord diseases, diseases and conditions of the endocrine system, namely growth and thyroid disorders, diseases and conditions of the genito-urinary system, namely, cancer, infertility, sexually transmitted diseases, incontinence, and sexual dysfunction, infectious diseases, namely respiratory infections, bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections none of the aforesaid wares are for use in the veterinary field or for use in association with autoimmune and inflammatory diseases and conditions; pharmaceutical preparations for oral ingestion for the treatment of diseases and conditions of the respiratory system, diseases and conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases and conditions of the gastro-intestinal system, diseases and conditions of the central nervous system, namely encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, Huntington's disease and multiple sclerosis, central nervous system infections, brain diseases, nervous system infections movement disorders, ocular motility disorders, spinal cord diseases, diseases and conditions of the endocrine system, namely growth and thyroid disorders, diseases and conditions of the genito-urinary system, namely, cancer, infertility, sexually transmitted diseases, incontinence, and sexual dysfunction, infectious diseases, namely respiratory infections, bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections none of the aforesaid wares are for use in the veterinary field or for use in association with autoimmune and inflammatory diseases and conditions; pharmaceutical preparations for topical administration for the treatment of diseases and conditions of the respiratory system, diseases and conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases and conditions of the gastro-intestinal system, diseases and conditions of the central nervous system, namely encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, Huntington's disease and multiple sclerosis, central nervous system infections, brain diseases, nervous system infections movement disorders, ocular motility disorders, spinal cord diseases, diseases and conditions of the endocrine system, namely growth and thyroid disorders, diseases and conditions of the genito-urinary system, namely, cancer, infertility, sexually transmitted diseases, incontinence, and sexual dysfunction, infectious diseases, namely respiratory infections, bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections none of the aforesaid wares are for use in the veterinary field or for use in association with autoimmune and inflammatory diseases and conditions; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders none of the aforesaid wares are for use in the veterinary field or for use in association with autoimmune and inflammatory diseases and conditions; drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals none of the aforesaid wares are for use in the veterinary field or for use in association with autoimmune and inflammatory diseases and conditions; medicaments for the treatment of erectile dysfunction none of the aforesaid wares are for use in the veterinary field or for use in association with autoimmune and inflammatory diseases and conditions; medicaments for the treatment of chronic obstructive pulmonary disease none of the aforesaid wares are for use in the veterinary field or for use in association with autoimmune and inflammatory diseases and conditions; medicaments for the treatment of premature ejaculation none of the aforesaid wares are for use in the veterinary field or for use in association with autoimmune and inflammatory diseases and conditions; medicaments for the treatment of cystic fibrosis none of the aforesaid wares are for use in the veterinary field or for use in association with autoimmune and inflammatory diseases and conditions; medicaments for the treatment of female sexual dysfunction none of the aforesaid wares are for use in the veterinary field or for use in association with autoimmune and inflammatory diseases and conditions; medicaments for the treatment of migraines none of the aforesaid wares are for use in the veterinary field or for use in association with autoimmune and inflammatory diseases and conditions; medicaments for the treatment of asthma, none of the aforesaid wares are for use in the veterinary field or for use in association with autoimmune and inflammatory diseases and conditions.

27.

vectura

      
Numéro d'application 1338736
Statut Enregistrée
Date de dépôt 2016-11-03
Date d'enregistrement 2016-11-03
Propriétaire Vectura Limited (Royaume‑Uni)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 10 - Appareils et instruments médicaux
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Medical preparations; pharmaceutical preparations for medical purposes; biological preparations for medical purposes; pharmaceutical preparations formulated for pulmonary delivery via inhalation; pharmaceutical preparations for the prevention or treatment of diseases or conditions of the respiratory and cardiovascular systems. Medical apparatus and instruments; inhalers; metered dose inhalers; active dry powder inhalers; passive dry powder inhalers; nebulisers for respiration therapy; respirators for artificial respiration; parts and fittings for all the aforesaid goods. Scientific research, development, design, analysis, testing and investigation relating to medical preparations and drug delivery devices; medical research; research relating to drug delivery devices; research relating to drug formulation; pharmaceutical development; preparation and formulation of pharmaceuticals; device and product testing.

28.

JET MILLING METHOD

      
Numéro de document 02996072
Statut Délivré - en vigueur
Date de dépôt 2016-09-09
Date de disponibilité au public 2017-03-16
Date d'octroi 2020-06-30
Propriétaire VECTURA LIMITED (Royaume‑Uni)
Inventeur(s)
  • Manford, Fergus
  • Green, Matthew

Abrégé

Systems and methods are disclosed for simultaneously jet milling and conditioning particulate material comprising a grinding chamber and an aerosol generator arranged to supply liquid aerosol into the grinding chamber. A composition made by this method is also disclosed.

Classes IPC  ?

  • A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres
  • A61K 31/40 - Composés hétérocycliques ayant l'azote comme hétéro-atome d'un cycle, p. ex. guanéthidine ou rifamycines ayant des cycles à cinq chaînons avec un azote comme seul hétéro-atome d'un cycle, p. ex. sulpiride, succinimide, tolmétine, buflomédil
  • B02C 19/06 - Appareils utilisant un courant de fluides

29.

JET MILLING METHOD

      
Numéro d'application EP2016071321
Numéro de publication 2017/042341
Statut Délivré - en vigueur
Date de dépôt 2016-09-09
Date de publication 2017-03-16
Propriétaire VECTURA LIMITED (Royaume‑Uni)
Inventeur(s)
  • Manford, Fergus
  • Green, Matthew

Abrégé

Systems and methods are disclosed for simultaneously jet milling and conditioning particulate material comprising a grinding chamber and an aerosol generator arranged to supply liquid aerosol into the grinding chamber. A composition made by this method is also disclosed.

Classes IPC  ?

  • A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres
  • A61K 31/40 - Composés hétérocycliques ayant l'azote comme hétéro-atome d'un cycle, p. ex. guanéthidine ou rifamycines ayant des cycles à cinq chaînons avec un azote comme seul hétéro-atome d'un cycle, p. ex. sulpiride, succinimide, tolmétine, buflomédil
  • B02C 19/06 - Appareils utilisant un courant de fluides

30.

vectura

      
Numéro d'application 1333791
Statut Enregistrée
Date de dépôt 2016-11-25
Date d'enregistrement 2016-11-25
Propriétaire Vectura Limited (Royaume‑Uni)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 10 - Appareils et instruments médicaux
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Medical preparations; pharmaceutical preparations for medical purposes; biological preparations for medical purposes; pharmaceutical preparations formulated for pulmonary delivery via inhalation; pharmaceutical preparations for the prevention or treatment of diseases or conditions of the respiratory and cardiovascular systems. Medical apparatus and instruments; drug delivery devices; inhalers; metered dose inhalers; active dry powder inhalers; passive dry powder inhalers; nebulisers for respiration therapy; respirators for artificial respiration; parts and fittings for all the aforesaid goods. Scientific research, development, design, analysis, testing and investigation relating to medical preparations and drug delivery devices; medical research; research relating to drug delivery devices; research relating to drug formulation; pharmaceutical development; preparation and formulation of pharmaceuticals; device and product testing.

31.

CRYSTALLINE FORM OF A JAK3 KINASE INHIBITOR

      
Numéro d'application EP2016054237
Numéro de publication 2016/142201
Statut Délivré - en vigueur
Date de dépôt 2016-02-29
Date de publication 2016-09-15
Propriétaire VECTURA LIMITED (Royaume‑Uni)
Inventeur(s) Holland, Joanne

Abrégé

The invention relates to novel co-crystals of a drug substance and their use to treat respiratory diseases such as asthma and COPD.

Classes IPC  ?

  • C07D 471/04 - Systèmes condensés en ortho
  • A61K 31/437 - Composés hétérocycliques ayant l'azote comme hétéro-atome d'un cycle, p. ex. guanéthidine ou rifamycines ayant des cycles à six chaînons avec un azote comme seul hétéro-atome d'un cycle condensés en ortho ou en péri avec des systèmes hétérocycliques le système hétérocyclique contenant un cycle à cinq chaînons ayant l'azote comme hétéro-atome du cycle, p. ex. indolizine, bêta-carboline
  • A61P 11/00 - Médicaments pour le traitement des troubles du système respiratoire

32.

POLYMORPHIC FORMS OF (S)-3-(3(1-METHYL-2-OXO-5-(PYRAZOLO[1,5-A]PYRIDINE-3(2H)-YL)PIPERIDIN-1-YL)-3-OXOPROPANENITRILE

      
Numéro de document 02972977
Statut Délivré - en vigueur
Date de dépôt 2016-01-27
Date de disponibilité au public 2016-08-11
Date d'octroi 2019-04-09
Propriétaire VECTURA LIMITED (Royaume‑Uni)
Inventeur(s) Munro, Alexander

Abrégé

The invention relates to polymorphic forms of (S)-3-(3-(1-methyl-2-oxo-5-(pyrazolo[1,5-a]py yl)-1H-imidazo[4,5-b]pyridine-3(2H)-yl)piperidin-1-yl)-3-oxopropanenitrile and their use as therapeutic agents for the treatment of respiratory diseases.

Classes IPC  ?

  • A61K 31/4545 - Pipéridines non condensées, p. ex. pipérocaïne contenant d'autres systèmes hétérocycliques contenant un cycle à six chaînons avec l'azote comme hétéro-atome du cycle, p. ex. pipampérone, anabasine
  • A61P 11/06 - Antiasthmatiques
  • C07D 519/00 - Composés hétérocycliques contenant plusieurs systèmes de plusieurs hétérocycles déterminants condensés entre eux ou condensés avec un système carbocyclique commun non prévus dans les groupes ou

33.

NOVEL POLYMORPHS

      
Numéro d'application EP2016051691
Numéro de publication 2016/124464
Statut Délivré - en vigueur
Date de dépôt 2016-01-27
Date de publication 2016-08-11
Propriétaire VECTURA LIMITED (Royaume‑Uni)
Inventeur(s) Munro, Alexander

Abrégé

The invention relates to polymorphic forms of (S)-3-(3-(1-methyl-2-oxo-5-(pyrazolo[1,5-a]py yl)-1H-imidazo[4,5-b]pyridine-3(2H)-yl)piperidin-1-yl)-3-oxopropanenitrile and their use as therapeutic agents for the treatment of respiratory diseases.

Classes IPC  ?

  • C07D 519/00 - Composés hétérocycliques contenant plusieurs systèmes de plusieurs hétérocycles déterminants condensés entre eux ou condensés avec un système carbocyclique commun non prévus dans les groupes ou
  • A61K 31/437 - Composés hétérocycliques ayant l'azote comme hétéro-atome d'un cycle, p. ex. guanéthidine ou rifamycines ayant des cycles à six chaînons avec un azote comme seul hétéro-atome d'un cycle condensés en ortho ou en péri avec des systèmes hétérocycliques le système hétérocyclique contenant un cycle à cinq chaînons ayant l'azote comme hétéro-atome du cycle, p. ex. indolizine, bêta-carboline
  • A61P 11/06 - Antiasthmatiques

34.

vectura

      
Numéro d'application 015655319
Statut Enregistrée
Date de dépôt 2016-07-13
Date d'enregistrement 2016-11-03
Propriétaire VECTURA LIMITED (Royaume‑Uni)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 10 - Appareils et instruments médicaux
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Chemical substances and products for use in the manufacture of medical preparations. Medical preparations; pharmaceutical preparations for medical purposes; biological preparations for medical purposes; pharmaceutical preparations formulated for pulmonary delivery via inhalation; pharmaceutical preparations for the prevention or treatment of diseases or conditions of the respiratory and cardiovascular systems. Medical apparatus and instruments; drug delivery devices; inhalers; metered dose inhalers; active dry powder inhalers; passive dry powder inhalers; nebulisers for respiration therapy; respirators for artificial respiration; parts and fittings for all the aforesaid goods. Scientific research, development, design, analysis, testing and investigation relating to medical preparations and drug delivery devices; medical research; research relating to drug delivery devices; research relating to drug formulation; pharmaceutical development; preparation and formulation of pharmaceuticals; device and product testing.

35.

vectura

      
Numéro d'application 015509541
Statut Enregistrée
Date de dépôt 2016-06-03
Date d'enregistrement 2016-10-06
Propriétaire VECTURA LIMITED (Royaume‑Uni)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 10 - Appareils et instruments médicaux
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Chemical substances and products for use in the manufacture of medical preparations. Medical preparations; pharmaceutical preparations for medical purposes; biological preparations for medical purposes; pharmaceutical preparations formulated for pulmonary delivery via inhalation; pharmaceutical preparations for the prevention or treatment of diseases or conditions of the respiratory and cardiovascular systems. Medical apparatus and instruments; drug delivery devices; inhalers; metered dose inhalers; active dry powder inhalers; passive dry powder inhalers; nebulisers for respiration therapy; respirators for artificial respiration; parts and fittings for all the aforesaid goods. Scientific research, development, design, analysis, testing and investigation relating to medical preparations and drug delivery devices; medical research; research relating to drug delivery devices; research relating to drug formulation; pharmaceutical development; preparation and formulation of pharmaceuticals; device and product testing.

36.

Miscellaneous Design

      
Numéro d'application 015507254
Statut Enregistrée
Date de dépôt 2016-06-03
Date d'enregistrement 2016-10-06
Propriétaire VECTURA LIMITED (Royaume‑Uni)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 10 - Appareils et instruments médicaux
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Chemical substances and products for use in the manufacture of medical preparations. Medical preparations; pharmaceutical preparations for medical purposes; biological preparations for medical purposes; pharmaceutical preparations formulated for pulmonary delivery via inhalation; pharmaceutical preparations for the prevention or treatment of diseases or conditions of the respiratory and cardiovascular systems. Medical apparatus and instruments; drug delivery devices; inhalers; metered dose inhalers; active dry powder inhalers; passive dry powder inhalers; nebulisers for respiration therapy; respirators for artificial respiration; parts and fittings for all the aforesaid goods. Scientific research, development, design, analysis, testing and investigation relating to medical preparations and drug delivery devices; medical research; research relating to drug delivery devices; research relating to drug formulation; pharmaceutical development; preparation and formulation of pharmaceuticals; device and product testing.

37.

FORMULATION COMPRISING GLYCOPYRROLATE, METHOD AND APPARATUS

      
Numéro de document 02960694
Statut Délivré - en vigueur
Date de dépôt 2015-09-09
Date de disponibilité au public 2016-03-17
Date d'octroi 2021-05-04
Propriétaire VECTURA LIMITED (Royaume‑Uni)
Inventeur(s) Manford, Fergus

Abrégé

A method is disclosed for making a pharmaceutical composition for pulmonary administration comprising co-jet milling glycopyrrolate and magnesium stearate, wherein the co-jet milled glycopyrrolate and magnesium stearate is then subjected to a conditioning step which includes exposure of the co-jet milled glycopyrrolate and magnesium stearate to humidity. A composition made by this method is also disclosed.

Classes IPC  ?

  • A61J 3/02 - Dispositifs ou procédés spécialement conçus pour donner à des produits pharmaceutiques une forme physique déterminée ou une forme propre à leur administration la forme de poudres
  • A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres

38.

FORMULATION COMPRISING GLYCOPYRROLATE, METHOD AND APPARATUS

      
Numéro d'application EP2015070660
Numéro de publication 2016/038116
Statut Délivré - en vigueur
Date de dépôt 2015-09-09
Date de publication 2016-03-17
Propriétaire VECTURA LIMITED (Royaume‑Uni)
Inventeur(s) Manford, Fergus

Abrégé

A method is disclosed for making a pharmaceutical composition for pulmonary administration comprising co-jet milling glycopyrrolate and magnesium stearate, wherein the co-jet milled glycopyrrolate and magnesium stearate is then subjected to a conditioning step which includes exposure of the co-jet milled glycopyrrolate and magnesium stearate to humidity. A composition made by this method is also disclosed.

Classes IPC  ?

  • A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
  • A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres
  • A61K 9/16 - AgglomérésGranulésMicrobilles
  • A61K 31/00 - Préparations médicinales contenant des ingrédients actifs organiques

39.

Use of stearate in an inhalable formulation

      
Numéro d'application 14779382
Numéro de brevet 10022323
Statut Délivré - en vigueur
Date de dépôt 2014-03-28
Date de la première publication 2016-02-18
Date d'octroi 2018-07-17
Propriétaire VECTURA LIMITED (Royaume‑Uni)
Inventeur(s) Green, Matthew

Abrégé

The present invention concerns a method for making an inhaled pharmaceutical composition with improved powder handling properties comprising a stearate, a method of preparing such a composition, and the use of such a stearate in a composition when dispensed into a receptacle for use in a dry powder inhaler receptacle.

Classes IPC  ?

  • A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
  • A61K 31/56 - Composés contenant des systèmes cycliques du cyclopenta[a]hydrophénanthrèneLeurs dérivés, p. ex. stéroïdes
  • A61K 47/12 - Acides carboxyliquesLeurs sels ou anhydrides

40.

METHOD AND APPARATUS FOR MAKING COMPOSITIONS FOR PULMONARY ADMINISTRATION

      
Numéro d'application GB2014052973
Numéro de publication 2015/049519
Statut Délivré - en vigueur
Date de dépôt 2014-10-01
Date de publication 2015-04-09
Propriétaire VECTURA LIMITED (Royaume‑Uni)
Inventeur(s) Green, Matthew

Abrégé

A method is disclosed for making a pharmaceutical composition for pulmonary administration comprising a pharmaceutically active protein or nucleic acid particle, the method comprising a step in which the inhalable pharmaceutically active protein or nucleic acid particle is acoustically blended in a resonant acoustic blender. The invention also relates to compositions for inhalation prepared by the method.

Classes IPC  ?

  • A61K 9/72 - Préparations médicinales caractérisées par un aspect particulier à fumer ou inhaler
  • A61K 39/00 - Préparations médicinales contenant des antigènes ou des anticorps
  • B01F 11/02 - Mélangeurs avec mécanismes à secousses, oscillants ou vibrants au moyen de vibrations ultrasonores

41.

USE OF STEARATE IN AN INHALABLE FORMULATION

      
Numéro de document 02907658
Statut Délivré - en vigueur
Date de dépôt 2014-03-28
Date de disponibilité au public 2014-10-02
Date d'octroi 2020-03-24
Propriétaire VECTURA LIMITED (Royaume‑Uni)
Inventeur(s) Green, Matthew

Abrégé

The present invention concerns a method for making an inhaled pharmaceutical composition with improved powder handling properties comprising a stearate, a method of preparing such a composition, and the use of such a stearate in a composition when dispensed into a receptacle for use in a dry powder inhaler receptacle.

Classes IPC  ?

  • A61K 9/72 - Préparations médicinales caractérisées par un aspect particulier à fumer ou inhaler

42.

USE OF STEARATE IN AN INHALABLE FORMULATION

      
Numéro d'application GB2014051003
Numéro de publication 2014/155134
Statut Délivré - en vigueur
Date de dépôt 2014-03-28
Date de publication 2014-10-02
Propriétaire VECTURA LIMITED (Royaume‑Uni)
Inventeur(s) Green, Matthew

Abrégé

The present invention concerns a method for making an inhaled pharmaceutical composition with improved powder handling properties comprising a stearate, a method of preparing such a composition, and the use of such a stearate in a composition when dispensed into a receptacle for use in a dry powder inhaler receptacle.

Classes IPC  ?

  • A61K 9/72 - Préparations médicinales caractérisées par un aspect particulier à fumer ou inhaler

43.

TAURINE COMPOSITIONS SUITABLE FOR INHALATION

      
Numéro d'application GB2014050953
Numéro de publication 2014/155103
Statut Délivré - en vigueur
Date de dépôt 2014-03-26
Date de publication 2014-10-02
Propriétaire VECTURA LIMITED (Royaume‑Uni)
Inventeur(s)
  • Farrow, David
  • Coggins, Katie

Abrégé

The invention discloses spray-dried compositions for inhalation and methods for preparing such powder compositions. The compositions of the invention are produced by spray-drying taurine under conditions that (i) retain the physical and chemical stability of the composition during spray drying and upon storage, (ii) protect the powder composition from aggregation and (iii) provide particles suitable for aerosolisation.

Classes IPC  ?

  • A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
  • A61K 47/20 - Composés organiques, p. ex. hydrocarbures naturels ou synthétiques, polyoléfines, huile minérale, gelée de pétrole ou ozocérite contenant du soufre, p. ex. sulfoxyde de diméthyle [DMSO], docusate, laurylsulfate de sodium ou acides aminosulfoniques
  • A61K 9/16 - AgglomérésGranulésMicrobilles
  • A61K 31/137 - Arylalkylamines, p. ex. amphétamine, épinéphrine, salbutamol, éphédrine
  • A61K 31/40 - Composés hétérocycliques ayant l'azote comme hétéro-atome d'un cycle, p. ex. guanéthidine ou rifamycines ayant des cycles à cinq chaînons avec un azote comme seul hétéro-atome d'un cycle, p. ex. sulpiride, succinimide, tolmétine, buflomédil
  • A61K 31/4045 - Indole-alkylaminesLeurs amides, p. ex. sérotonine, mélatonine
  • C07C 309/14 - Acides sulfoniques ayant des groupes sulfo liés à des atomes de carbone acycliques d'un squelette carboné acyclique saturé contenant des atomes d'azote, ne faisant pas partie de groupes nitro ou nitroso, liés au squelette carboné contenant des groupes amino liés au squelette carboné
  • A61P 11/00 - Médicaments pour le traitement des troubles du système respiratoire

44.

INHALER AND FORMULATION

      
Numéro d'application GB2013050001
Numéro de publication 2014/106727
Statut Délivré - en vigueur
Date de dépôt 2013-01-03
Date de publication 2014-07-10
Propriétaire VECTURA LIMITED (Royaume‑Uni)
Inventeur(s) Western, Karen Lisa

Abrégé

A dry powder formulation suitable for delivery by inhalation comprising an antifungal agent and a force control agent.

Classes IPC  ?

  • A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
  • A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres
  • A61K 31/496 - Pipérazines non condensées contenant d'autres hétérocycles, p. ex. rifampine, thiothixène ou sparfloxacine

45.

N-containing heteroaryl derivatives as JAK3 kinase inhibitors

      
Numéro d'application 13930392
Numéro de brevet 08946257
Statut Délivré - en vigueur
Date de dépôt 2013-06-28
Date de la première publication 2013-10-31
Date d'octroi 2015-02-03
Propriétaire Vectura Limited (Royaume‑Uni)
Inventeur(s) Solana, Jorge Salas

Abrégé

N-containing heteroaryl derivatives of formula I or II, wherein the meanings for the various substituents are as disclosed in the description. These compounds are useful as JAK, particularly JAK3, kinase inhibitors.

Classes IPC  ?

  • A61K 31/437 - Composés hétérocycliques ayant l'azote comme hétéro-atome d'un cycle, p. ex. guanéthidine ou rifamycines ayant des cycles à six chaînons avec un azote comme seul hétéro-atome d'un cycle condensés en ortho ou en péri avec des systèmes hétérocycliques le système hétérocyclique contenant un cycle à cinq chaînons ayant l'azote comme hétéro-atome du cycle, p. ex. indolizine, bêta-carboline
  • C07D 471/04 - Systèmes condensés en ortho
  • C07D 473/00 - Composés hétérocycliques contenant des systèmes cycliques purine
  • C07D 519/00 - Composés hétérocycliques contenant plusieurs systèmes de plusieurs hétérocycles déterminants condensés entre eux ou condensés avec un système carbocyclique commun non prévus dans les groupes ou

46.

METHOD AND APPARATUS

      
Numéro d'application GB2013050847
Numéro de publication 2013/144655
Statut Délivré - en vigueur
Date de dépôt 2013-03-28
Date de publication 2013-10-03
Propriétaire VECTURA LIMITED (Royaume‑Uni)
Inventeur(s) Green, Matthew

Abrégé

A method is disclosed for making a pharmaceutical composition for pulmonary administration, the method comprising a step in which an inhalable pharmaceutically active material is acoustically blended in a resonant acoustic blender. The invention also relates to compositions for inhalation prepared by the method.

Classes IPC  ?

  • B01F 11/02 - Mélangeurs avec mécanismes à secousses, oscillants ou vibrants au moyen de vibrations ultrasonores
  • A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier

47.

N-containing heteroaryl derivatives as JAK3 kinase inhibitors

      
Numéro d'application 13504157
Numéro de brevet 08501735
Statut Délivré - en vigueur
Date de dépôt 2010-10-29
Date de la première publication 2013-05-23
Date d'octroi 2013-08-06
Propriétaire VECTURA LIMITED (Royaume‑Uni)
Inventeur(s)
  • Rosales, Carmen Almansa
  • Solana, Jorge Salas
  • Soliva, Robert Soliva
  • Escrich, Sergio Rodriguez
  • González, Maria Cristina Sicre

Abrégé

N-containing heteroaryl derivatives of formula I or II, wherein the meanings for the various substituents are as disclosed in the description. These compounds are useful as JAK, particularly JAK3, kinase inhibitors.

Classes IPC  ?

  • A61K 31/52 - Purines, p. ex. adénine
  • A61K 31/522 - Purines, p. ex. adénine ayant des groupes oxo liés directement à l'hétérocycle, p. ex. hypoxanthine, guanine, acyclovir
  • C07D 473/00 - Composés hétérocycliques contenant des systèmes cycliques purine

48.

Ingredients for inhalation and methods for making the same

      
Numéro d'application 13514672
Numéro de brevet 09381189
Statut Délivré - en vigueur
Date de dépôt 2010-12-08
Date de la première publication 2012-12-06
Date d'octroi 2016-07-05
Propriétaire VECTURA LIMITED (Royaume‑Uni)
Inventeur(s)
  • Green, Matthew Michael James
  • Poole, Richard Michael

Abrégé

A method of processing an active ingredient, the method comprising submitting a pharmaceutically active ingredient in the absence of excipients and/or additives to compression and shearing forces. The invention also relates to compositions comprising an active prepared by the method.

Classes IPC  ?

  • A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres
  • A61K 31/404 - Indoles, p. ex. pindolol
  • B02C 23/00 - Procédés auxiliaires, dispositifs auxiliaires ou accessoires spécialement adaptés au broyage ou à la désagrégation non prévus dans les groupes ou non adaptés spécialement aux appareillages couverts par un seul des groupes
  • C07D 209/16 - Tryptamines
  • A61K 31/4045 - Indole-alkylaminesLeurs amides, p. ex. sérotonine, mélatonine
  • A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier

49.

GLUCOSAMINOGLUCANS SUCH AS HEPARIN FOR USE IN THE TREATMENT OF PULMONARY INFLAMMATION SUCH AS COPD

      
Numéro d'application GB2011052366
Numéro de publication 2012/073025
Statut Délivré - en vigueur
Date de dépôt 2011-11-30
Date de publication 2012-06-07
Propriétaire VECTURA LIMITED (Royaume‑Uni)
Inventeur(s) Morgan, Frazer Giles

Abrégé

According to the invention there is provided heparin for use in the treatment of COPD, wherein, after administration to a subject, the heparin reduces inflammation in the lungs of the subject.

Classes IPC  ?

  • A61K 31/726 - Glycosaminoglycanes, c.-à-d. mucopolysaccharides
  • A61K 31/727 - HéparineHéparane
  • A61P 11/06 - Antiasthmatiques
  • A61P 11/00 - Médicaments pour le traitement des troubles du système respiratoire

50.

APOMORPHINE BY PULMONARY INHALATION, OPRIONALLY IN COMBINATION WITH L-DOPA OR A DOPAMINE AGONIST FOR USE IN THE TREATMENT OF PARKINSON

      
Numéro d'application GB2011052222
Numéro de publication 2012/066319
Statut Délivré - en vigueur
Date de dépôt 2011-11-15
Date de publication 2012-05-24
Propriétaire VECTURA LIMITED (Royaume‑Uni)
Inventeur(s)
  • Morgan, Frazer Giles
  • Main, Mark Jonathan

Abrégé

According to the invention there is provided a method of treating and/or preventing the symptoms of Parkinson's disease comprising delivering apomorphine, optionally in combination with levodopa and/or a dopamine agonist that is not apomorphine, wherein apomorphine is administered by inhalation.

Classes IPC  ?

  • A61K 31/195 - Acides carboxyliques, p. ex. acide valproïque ayant un groupe amino
  • A61K 31/198 - Alpha-amino-acides, p. ex. alanine ou acide édétique [EDTA]
  • A61K 31/275 - NitrilesIsonitriles
  • A61K 31/4045 - Indole-alkylaminesLeurs amides, p. ex. sérotonine, mélatonine
  • A61K 31/428 - Thiazoles condensés avec des carbocycles
  • A61K 31/48 - Dérivés de l'ergoline, p. ex. acide lysergique, ergotamine
  • A61K 31/485 - Dérivés du morphinane, p. ex. morphine, codéine
  • A61P 25/16 - Antiparkinsoniens

51.

VECTURA

      
Numéro d'application 156114500
Statut Enregistrée
Date de dépôt 2012-01-24
Date d'enregistrement 2019-07-11
Propriétaire Vectura Limited (Royaume‑Uni)
Classes de Nice  ?
  • 10 - Appareils et instruments médicaux
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception
  • 45 - Services juridiques; services de sécurité; services personnels pour individus

Produits et services

(1) Inhalers for therapeutic use. (1) Scientific research, development, design, analysis, testing and investigation in the field of pharmaceutical preparations and drug delivery devices; medical research; research in the field of drug delivery devices; research in the field of drug formulation; pharmaceutical developments; preparation and formulation of pharmaceuticals; medical device testing services; exploitation of intellectual property, namely provision of licenses for pharmaceutical preparations, substances and products; provision of licences for medical apparatus and instruments; provision of licences for drug delivery devices; provision of licenses for pharmaceutical preparations for pulmonary delivery; provision of licences for intellectual property.

52.

Suspension formulations

      
Numéro d'application 12865142
Numéro de brevet 09011923
Statut Délivré - en vigueur
Date de dépôt 2009-02-02
Date de la première publication 2011-07-28
Date d'octroi 2015-04-21
Propriétaire Vectura Limited (Royaume‑Uni)
Inventeur(s)
  • Lewis, David Andrew
  • Keeble, Christina Alexandra
  • Whitfield, Nicola Kim
  • Church, Tanya

Abrégé

The present invention relates to suspension formulations, especially those for delivering a pharmaceutically active agent in aerosol form using a spray or aerosol device, such as a pressurized metered dose inhaler (pMDI). The formulations may be for pulmonary, nasal, buccal or topical administration, but are preferably for pulmonary inhalation.

Classes IPC  ?

  • A61K 9/50 - Microcapsules
  • A61K 9/12 - AérosolsMousses
  • A61P 11/08 - Bronchodilatateurs
  • A61P 11/06 - Antiasthmatiques
  • B29B 9/16 - Traitement auxiliaire de granulés
  • A61K 31/00 - Préparations médicinales contenant des ingrédients actifs organiques
  • A61K 31/167 - Amides, p. ex. acides hydroxamiques ayant des cycles aromatiques, p. ex. colchicine, aténolol, progabide ayant l'atome d'azote d'un groupe carboxamide lié directement au cycle aromatique, p. ex. lidocaïne, paracétamol
  • A61K 31/58 - Composés contenant des systèmes cycliques du cyclopenta[a]hydrophénanthrèneLeurs dérivés, p. ex. stéroïdes contenant des hétérocycles, p. ex. danazol, stanozolol, pancuronium ou digitogénine
  • A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier

53.

INGREDIENTS FOR INHALATION AND METHODS FOR MAKING THE SAME

      
Numéro de document 02782725
Statut Délivré - en vigueur
Date de dépôt 2010-12-08
Date de disponibilité au public 2011-06-16
Date d'octroi 2019-02-12
Propriétaire VECTURA LIMITED (Royaume‑Uni)
Inventeur(s)
  • Green, Matthew Michael James
  • Poole, Richard Michael

Abrégé

A method of processing an active ingredient, the method comprising submitting a pharmaceutically active ingredient in the absence of excipients and/or additives to compression and shearing forces. The invention also relates to compositions comprising an active prepared by the method.

Classes IPC  ?

  • A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
  • A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres
  • A61K 9/16 - AgglomérésGranulésMicrobilles
  • A61K 9/51 - Nanocapsules
  • A61K 31/4045 - Indole-alkylaminesLeurs amides, p. ex. sérotonine, mélatonine

54.

PROCESS AND PRODUCT

      
Numéro d'application GB2010052053
Numéro de publication 2011/070361
Statut Délivré - en vigueur
Date de dépôt 2010-12-08
Date de publication 2011-06-16
Propriétaire VECTURA LIMITED (Royaume‑Uni)
Inventeur(s)
  • Green, Matthew Michael James
  • Poole, Richard Michael

Abrégé

A method of processing an active ingredient, the method comprising submitting a pharmaceutically active ingredient in the absence of excipients and/or additives to compression and shearing forces. The invention also relates to compositions comprising an active prepared by the method.

Classes IPC  ?

  • A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres
  • A61K 9/16 - AgglomérésGranulésMicrobilles
  • A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
  • A61K 9/51 - Nanocapsules
  • A61K 31/4045 - Indole-alkylaminesLeurs amides, p. ex. sérotonine, mélatonine

55.

VECTURA

      
Numéro d'application 009292293
Statut Enregistrée
Date de dépôt 2010-08-03
Date d'enregistrement 2011-02-25
Propriétaire VECTURA LIMITED (Royaume‑Uni)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 10 - Appareils et instruments médicaux
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Chemical substances and products for use in the manufacture of medical preparations. Pharmaceutical and veterinary preparations, substances and products; chemical preparations and products for medical and veterinary purposes, all for administration to human or animal patients; pharmaceutical preparations for pulmonary delivery; inhalants; powders for inhalers; powders for asthma inhalers; powders for transdermal injection; pharmaceutical and veterinary preparations for oral ingestion; pharmaceutical and veterinary preparations for topical administration; all the above goods not for use in the dental field. Medical and veterinary apparatus, articles and aids, all for the administration of pharmaceutical preparations to human or animal patients; devices for the administration of pharmaceutical preparations; drug delivery devices; devices for metering and/or dispensing pharmaceutical preparations; inhalers; dry powder inhalers; inhalers for the treatment of asthma; nebulisers;  parts and fittings for all the aforesaid goods; all the above goods not for use in the dental field. Scientific research, development, design, analysis, testing and investigation relating to pharmaceutical preparations and drug delivery devices; medical research; research relating to drug delivery devices; research relating to drug formulation; pharmaceutical development; preparation and formulation of pharmaceuticals; device and product testing; exploitation of intellectual property; provision of licences for pharmaceutical preparations, substances and products; provision of licences for medical and veterinary apparatus and instruments; provision of licences for drug delivery devices; provision of licenses for pharmaceutical preparations for pulmonary delivery; provision of licences for intellectual property.

56.

SUSPENSION FORMULATIONS

      
Numéro d'application GB2009000261
Numéro de publication 2009/095681
Statut Délivré - en vigueur
Date de dépôt 2009-02-02
Date de publication 2009-08-06
Propriétaire
  • VECTURA LIMITED (Royaume‑Uni)
  • INNOVATA BIOMED LIMITED (Royaume‑Uni)
Inventeur(s)
  • Lewis, David, Andrew
  • Keeble, Christina, Alexandra
  • Whitfield, Nicola, Kim
  • Church, Tanya

Abrégé

The present invention relates to suspension formulations, especially those for delivering a pharmaceutically active agent in aerosol form using a spray or aerosol device, such as a pressurised metered dose inhaler (pMDI). The formulations may be for pulmonary, nasal, buccal or topical administration, but are preferably for pulmonary inhalation. The suspension fomulation comprises particles of active agent, a propellant one or more suspension stabiliser (amino acid, leucine, saccharide, disaccharide, trehalose) and/or a co-solvent (alcohol, ethanol).

Classes IPC  ?

  • A61K 9/12 - AérosolsMousses
  • A61K 9/72 - Préparations médicinales caractérisées par un aspect particulier à fumer ou inhaler

57.

PULMONARY FORMULATIONS OF TRIPTANS

      
Numéro d'application GB2009000265
Numéro de publication 2009/095684
Statut Délivré - en vigueur
Date de dépôt 2009-02-02
Date de publication 2009-08-06
Propriétaire VECTURA LIMITED (Royaume‑Uni)
Inventeur(s) Main, Mark, Jonathan

Abrégé

The present invention relates to pharmaceutical compositions comprising triptans, such as sumatriptan, and their uses in therapy. In particular, the invention relates to compositions for administration via the inhaled route.

Classes IPC  ?

  • A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres
  • A61K 9/72 - Préparations médicinales caractérisées par un aspect particulier à fumer ou inhaler
  • A61K 31/4045 - Indole-alkylaminesLeurs amides, p. ex. sérotonine, mélatonine
  • A61K 31/4196 - 1,2,4-Triazoles
  • A61K 31/422 - Oxazoles non condensés et contenant d'autres hétérocycles
  • A61K 31/454 - Pipéridines non condensées, p. ex. pipérocaïne contenant d'autres systèmes hétérocycliques contenant un cycle à cinq chaînons avec l'azote comme hétéro-atome du cycle, p. ex. pimozide, dompéridone
  • A61P 25/06 - Agents antimigraineux

58.

COMPOSITIONS FOR TREATING PARKINSON'S DISEASE

      
Numéro d'application GB2008003698
Numéro de publication 2009/056851
Statut Délivré - en vigueur
Date de dépôt 2008-10-31
Date de publication 2009-05-07
Propriétaire VECTURA LIMITED (Royaume‑Uni)
Inventeur(s)
  • Ganderton, David
  • Main, Mark, Jonathan
  • Morgan, Fraser, Giles

Abrégé

The present invention relates to improved treatment of diseases and disorders of the central nervous system by administration of apomorphine. In particular, the administration is via pulmonary inhalation. The invention provides the means for improving the treatment of a number of conditions, including Parkinson's Disease.

Classes IPC  ?

  • A61K 9/16 - AgglomérésGranulésMicrobilles
  • A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres
  • A61K 9/72 - Préparations médicinales caractérisées par un aspect particulier à fumer ou inhaler
  • A61K 31/485 - Dérivés du morphinane, p. ex. morphine, codéine
  • A61P 25/16 - Antiparkinsoniens

59.

INHALER DEVICES AND BESPOKE PHARMACEUTICAL COMPOSITIONS

      
Numéro d'application GB2007050674
Numéro de publication 2008/053253
Statut Délivré - en vigueur
Date de dépôt 2007-11-05
Date de publication 2008-05-08
Propriétaire VECTURA LIMITED (Royaume‑Uni)
Inventeur(s) Morton, David

Abrégé

The present invention relates to inhaler devices and bespoke pharmaceutical dry powder composition to be dispensed using such inhaler devices for pulmonary administration. In particular, the present invention relates to the provision of passive inhaler devices and dry powder compositions which are specifically formulated and prepared to be efficiently dispensed by such devices to reproducibly achieve a high delivered dose of the pharmaceutically active agent.

Classes IPC  ?

  • A61K 9/72 - Préparations médicinales caractérisées par un aspect particulier à fumer ou inhaler
  • A61M 15/00 - Inhalateurs

60.

IMPROVEMENTS IN TREATMENT OF DRY POWDER FORMULATIONS

      
Numéro d'application GB2007050142
Numéro de publication 2007/107796
Statut Délivré - en vigueur
Date de dépôt 2007-03-22
Date de publication 2007-09-27
Propriétaire VECTURA LIMITED (Royaume‑Uni)
Inventeur(s)
  • Morton, David
  • Kamlag, Yorick

Abrégé

The present invention relates to the treatment of dry powder formulations, doses of which are measured out and placed into receptacles such as blisters or capsules, to be dispensed by a dry powder inhaler device (DPI). In particular, the present invention relates to methods of agitating a dose of a dry powder formulation to ensure that any compacted powder is broken up. It is easier to extract a loose powder from a receptacle than it is to extract powder which is compacted and so ensuring that the powder in a receptacle is not compacted can, in turn, lead to improvements in the administration of the powder formulation to the lung of the patient.

Classes IPC  ?

  • A61M 15/00 - Inhalateurs
  • B01F 11/02 - Mélangeurs avec mécanismes à secousses, oscillants ou vibrants au moyen de vibrations ultrasonores
  • B65B 1/24 - Réduction du volume du matériau à remplir par compression mécanique

61.

V

      
Numéro d'application 900574
Statut Enregistrée
Date de dépôt 2006-03-22
Date d'enregistrement 2006-03-22
Propriétaire Vectura Limited (Royaume‑Uni)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 10 - Appareils et instruments médicaux
  • 16 - Papier, carton et produits en ces matières
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Pharmaceutical and veterinary preparations; medicaments formulated for pulmonary delivery; medicaments for inhalation; medicaments for erectile dysfunction; medicaments for chronic obstructive pulmonary disease; medicaments for premature ejaculation; medicaments for cystic fibrosis; medicaments for female sexual dysfunction; medicaments for migraine; medicaments for asthma. Surgical, medical, dental and veterinary apparatus and instruments, drug delivery devices; inhalers; active dry powder inhalers; passive dry powder inhalers; nebulisers; parts and fittings for all of the aforesaid goods. Paper, cardboard and goods made from these materials, not included in other classes; printed matter; photographs; stationery; instructional and teaching material (except apparatus); plastic materials for packaging (not included in other classes); all the aforesaid being goods relating to pharmaceuticals or drug delivery devices. Scientific and technological services and research and design relating thereto; industrial analysis and research services; pharmaceutical development services; preparation and/or formulation of pharmaceuticals; device and product testing services.

62.

VECTURA

      
Numéro d'application 900625
Statut Enregistrée
Date de dépôt 2005-08-23
Date d'enregistrement 2005-08-23
Propriétaire Vectura Limited (Royaume‑Uni)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 10 - Appareils et instruments médicaux
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Pharmaceutical and veterinary preparations; medicaments formulated for pulmonary delivery; medicaments for inhalation; medicaments for erectile dysfunction; medicaments for chronic obstructive pulmonary disease; medicaments for premature ejaculation; medicaments for cystic fibrosis; medicaments for female sexual dysfunction; medicaments for migraine; medicaments for asthma. Surgical, medical, dental and veterinary apparatus and instruments, drug delivery devices; inhalers; active dry powder inhalers; passive dry powder inhalers; nebulisers; parts and fittings for all of the aforesaid goods, but not including arthroscopic surgical instruments. Scientific and technological services and research and design relating thereto; industrial analysis and research services; pharmaceutical development services; preparation and/or formulation of pharmaceuticals; device and product testing services.

63.

Dry powder composition comprising co-jet milled particles for pulmonary inhalation

      
Numéro d'application 10571146
Numéro de brevet 08182838
Statut Délivré - en vigueur
Date de dépôt 2004-09-15
Date de la première publication 2006-11-16
Date d'octroi 2012-05-22
Propriétaire VECTURA LIMITED (Royaume‑Uni)
Inventeur(s)
  • Morton, David
  • Staniforth, John

Abrégé

The present invention relates to particles and to methods of making particles. In particular, the invention relates to methods of making composite active particles comprising a pharmaceutically active material for pulmonary inhalation, the method comprising a jet milling process.

Classes IPC  ?

  • A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
  • A61K 9/12 - AérosolsMousses
  • A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres

64.

DRY POWDER INHALER FORMULATIONS COMPRISING SURFACE-MODIFIED PARTICLES WITH ANTI-ADHERENT ADDITIVES

      
Numéro de document 02589514
Statut Délivré - en vigueur
Date de dépôt 2005-11-23
Date de disponibilité au public 2006-06-01
Date d'octroi 2014-07-22
Propriétaire VECTURA LIMITED (Royaume‑Uni)
Inventeur(s) Morton, David

Abrégé

The present invention is concerned with a refinement of the processing of particles that are to form a dry powder formulation which is to be administered to the lung using a dry powder inhaler (DPI) device. In particular, the present invention provides the processing of particles of active material and particles of carrier material in the presence of additive material to provide a powder composition which exhibits excellent powder properties and which is economical to produce.

Classes IPC  ?

  • A61K 9/12 - AérosolsMousses
  • A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres

65.

POWDERHALE

      
Numéro d'application 005141429
Statut Enregistrée
Date de dépôt 2006-05-31
Date d'enregistrement 2007-06-14
Propriétaire VECTURA LIMITED (Royaume‑Uni)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 16 - Papier, carton et produits en ces matières
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Chemicals for use in science and industry; chemical substances and products for use in the manufacture of medical preparations; chemicals for use in the manufacture of powders for medicinal use. Pharmaceutical and veterinary preparations; pharmaceutical and veterinary preparations for the treatment of diseases or conditions of the respiratory system; pharmaceutical and veterinary preparations for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions; pharmaceutical and veterinary preparations for the alleviation or prevention of pain or inflammation; inhalers filled with powders for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions; powders for asthma inhalers; powders for transdermal injection for the alleviation or prevention of pain, for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions; pharmaceutical and veterinary preparations for oral ingestion for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions; pharmaceutical and veterinary preparations for topical administration for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions; pharmaceutical and veterinary preparations for erectile dysfunction; pharmaceutical and veterinary preparations for chronic obstructive pulmonary disease; pharmaceutical and veterinary preparations for premature ejaculation; pharmaceutical and veterinary preparations for cystic fibrosis; pharmaceutical and veterinary preparations for female sexual dysfunction; medicaments for migraine; pharmaceutical and veterinary preparations for asthma. Printed matter; leaflets, brochures, labels, booklets, manuals, magazines, books, guides, pamphlets, catalogues, journals, newsletters, press releases, dossiers being collections of scientific papers, patient record cards, prescription pads, posters; packaging for pharmaceuticals and medical devices; instructional and teaching material, worksheets, work books, notes and note books, slides and images, pre-recorded CD-ROMs. Scientific and technological services and research and design relating thereto; industrial analysis and research services; medical and veterinary device development services; pharmaceutical development services; pharmaceutical delivery system development services; preparation and/or formulation of pharmaceuticals; medical and veterinary device and product testing services.

66.

Miscellaneous Design

      
Numéro d'application 004974093
Statut Enregistrée
Date de dépôt 2006-03-22
Date d'enregistrement 2007-04-11
Propriétaire VECTURA LIMITED (Royaume‑Uni)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 10 - Appareils et instruments médicaux
  • 16 - Papier, carton et produits en ces matières
  • 41 - Éducation, divertissements, activités sportives et culturelles
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Pharmaceutical and veterinary preparations; medicaments formulated for pulmonary delivery; medicaments for inhalation; medicaments for erectile dysfunction; medicaments for chronic obstructive pulmonary disease; medicaments for premature ejaculation; medicaments for cystic fibrosis; medicaments for female sexual dysfunction; medicaments for migraine; medicaments for asthma. Surgical, medical, dental and veterinary apparatus and instruments, drug delivery devices; inhalers; active dry powder inhalers; passive dry powder inhalers; nebulisers; parts and fittings for all of the aforesaid goods. Paper, cardboard and goods made from these materials, not included in other classes; printed matter; photographs; stationery; instructional and teaching material (except apparatus); plastic materials for packaging (not included in other classes); all the aforesaid being goods relating to pharmaceuticals or drug delivery devices. Education; providing of training; all the aforesaid being services relating to pharmaceuticals or drug delivery devices. Scientific and technological services and research and design relating thereto; industrial analysis and research services; pharmaceutical development services; preparation and/or formulation of pharmaceuticals; device and product testing services.

67.

PHARMACEUTICAL COMPOSITIONS COMPRISING GLYCOPYRROLATE

      
Numéro de document 02563760
Statut Délivré - en vigueur
Date de dépôt 2005-04-29
Date de disponibilité au public 2005-11-10
Date d'octroi 2013-07-02
Propriétaire VECTURA LIMITED (Royaume‑Uni)
Inventeur(s)
  • Morton, David
  • Shott, Martin
  • Davies, Rebecca

Abrégé

The present invention relates to pharmaceutical compositions comprising the antimuscarinic agent glycopyrrolate, for example the salt glycopyrronium bromide. In particular, the present invention relates to dry powder compositions which exhibit improved stability over time, and methods for producing the same.

Classes IPC  ?

  • A61K 9/12 - AérosolsMousses
  • A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres
  • A61K 31/40 - Composés hétérocycliques ayant l'azote comme hétéro-atome d'un cycle, p. ex. guanéthidine ou rifamycines ayant des cycles à cinq chaînons avec un azote comme seul hétéro-atome d'un cycle, p. ex. sulpiride, succinimide, tolmétine, buflomédil

68.

VECTURA

      
Numéro d'application 127618800
Statut Enregistrée
Date de dépôt 2005-10-18
Date d'enregistrement 2012-02-15
Propriétaire Vectura Limited (Royaume‑Uni)
Classes de Nice  ?
  • 40 - Traitement de matériaux; recyclage, purification de l'air et traitement de l'eau
  • 41 - Éducation, divertissements, activités sportives et culturelles
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

(1) Scientific and technological services and research and design relating thereto; industrial analysis and research services; all the aforesaid being services relating to pharmaceuticals or drug delivery devices; pharmaceutical development services; preparations and/or formulation of pharmaceuticals; medical device and medical product testing services; pharmaceutical product development.

69.

VECTURA

      
Numéro d'application 001748920
Statut Enregistrée
Date de dépôt 2000-07-10
Date d'enregistrement 2001-09-17
Propriétaire VECTURA LIMITED (Royaume‑Uni)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 10 - Appareils et instruments médicaux
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Chemical substances and products for use in the manufacture of medical preparations. Pharmaceutical and veterinary preparations, substances and products; chemical preparations and products for medical and veterinary purposes; all for administration to human or animal patients; inhalants; powders for inhalers; powders for asthma inhalers; powders for transdermal injection; pharmaceutical and veterinary preparations for oral ingestion; pharmaceutical and veterinary preparations for topical administration; all the above goods not for use in the dental field. Medical and veterinary apparatus, articles and aids and parts and fittings therefor; all for the administration of pharmaceutical preparations to human or animal patients; devices for the administration of pharmaceutical preparations; devices for metering and/or dispensing pharmaceutical preparations, inhalers and parts and fittings therefor; inhalers for the treatment of asthma and parts and fittings therefor; aerosol dispensers; all the above goods not for use in the dental field. Scientific research, development, design, testing and investigation relating to pharmaceutical preparations; medical research; research relating to drug delivery devices; research relating to drug formulation.